James Chappell, MD, PhD

Vanderbilt University Medical Center

Disclosure(s): Merck: Grant/Research Support

Poster(s):

• (P-670) Differences in Adenovirus Type Detection in Children with Acute Respiratory Illness versus Healthy Controls: New Vaccine Surveillance Network (NVSN) 2016-2019
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1193) Epidemiology of Respiratory Syncytial Virus in Young, Hospitalized Children in Jordan: A Prospective Viral Surveillance Study
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1209) Changes in Antiviral Prescription for Children with Influenza in U.S. Emergency Departments During the COVID-19 Pandemic: New Vaccine Surveillance Network (NVSN), 2016-2023
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-2366) Influenza-Specific Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic, New Vaccine Surveillance Network (2016–2023)
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT